High Shear Stress Reduces ERG Causing Endothelial-Mesenchymal Transition and Pulmonary Arterial Hypertension
Arteriosclerosis, Thrombosis, and Vascular Biology · 2025-02 · 45 (2) · 218-237
DOI: 10.1161/atvbaha.124.321092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2025-02. Verfasst von Tsutomu Shinohara und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics (T.S., J.-R.M., Y.H.C., J.M.S., J. Kaplan, A.C., L.W., D.G., S.T., S.I., M.D., W.Y., A.L.M., M.R.). Hauptthemen laut MEDLINE: Pulmonary Artery, Endothelial Cells, Epithelial-Mesenchymal Transition, Mechanotransduction, Cellular. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: American Heart Association-American Stroke Association, NIH HHS, NHGRI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Computational modeling indicated that pathological high shear stress (HSS; 100 dyn/cm 2 ) is generated in pulmonary arteries (PAs; 100–500 µm) in congenital heart defects causing PA hypertension (PAH) and in idiopathic PAH with occlusive vascular remodeling. Endothelial-to-mesenchymal transition (EndMT) is a feature of PAH. We hypothesize that HSS induces EndMT, contributing to the initiation and progression of PAH. METHODS: We used the Ibidi perfusion system to determine whether HSS applied to human PA endothelial cells (ECs) induces EndMT when compared with physiological laminar shear stress (15 dyn/cm 2 ). The mechanism was investigated and targeted to prevent PAH in a mouse with HSS induced by an aortocaval shunt. RESULTS: EndMT, a feature of PAH not previously attributed to HSS, was observed. HSS did not alter the induction of transcription factors KLF (Krüppel-like factor) 2/4, but an ERG (ETS-family transcription factor) was reduced, as were histone H3 lysine 27 acetylation enhancer-promoter peaks containing ERG motifs. Consequently, there was reduced interaction between ERG and KLF2/4, a feature important in tethering KLF and the chromatin remodeling complex to DNA. In PA ECs under laminar shear stress, reducing ERG by siRNA caused EndMT associated with decreased BMPR2 (bone morphogenetic protein receptor 2), CDH5 (cadherin 5), and PECAM1 (platelet and EC adhesion molecule 1) and increased SNAI1/2 (Snail/Slug) and ACTA2 (smooth muscle α2 actin). In PA ECs under HSS, transfection of ERG prevented EndMT. HSS was then induced in mice by an aortocaval shunt, causing progressive PAH over 8 weeks. An adeno-associated viral vector (AAV2-ESGHGYF) was used to replenish ERG selectively in PA ECs. Elevated PA pressure, EndMT, and vascular remodeling (muscularization of peripheral arteries) in the aortocaval shunt mice were markedly reduced by ERG delivery. CONCLUSIONS: Pathological HSS reduced lung EC ERG, resulting in EndMT and PAH. Agents that upregulate ERG could reverse HSS-mediated PAH and occlusive vascular remodeling resulting from high flow or narrowed PAs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics (T.S., J.-R.M., Y.H.C., J.M.S., J. Kaplan, A.C., L.W., D.G., S.T., S.I., M.D., W.Y., A.L.M., M.R.).
- Stanford Cardiovascular Institute (T.S., J.-R.M., Y.H.C., K.O., J.M.S., J. Kaplan, A.C., L.W., S.T., S.I., M.D., A.L.M., J.M.E., M.R.), Stanford University School of Medicine, CA.
- Vera Moulton Wall Center for Pulmonary Vascular Diseases (T.S., J.-R.M., Y.H.C., J.M.S., J. Kaplan, A.C., L.W., S.T., S.I., M.D., A.L.M., M.R.), Stanford University School of Medicine, CA.
- Basic Science and Engineering Initiative, Betty Irene Moore Children's Heart Center, Lucile Packard Children's Hospital (T.S., J.-R.M., Y.C.L.-Y., J. Kaplan, A.C., L.W., S.T., S.I., K.G., J.M.E., M.R.), Stanford Univers…
- Now with Department of Pediatrics and Neonatology, Nagoya City University Graduate School of Medical Sciences, Japan (T.S.).
- Now with Department of Pediatrics, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul (Y.H.C.).
ORCID-Profile: Tsutomu Shinohara, Jan-Renier Moonen, Yoon Hong Chun, Yannick C Lee-Yow, Kenichi Okamura, Jordan Kaplan, Sarasa Isobe, Melody Dong, Weiguang Yang, Laura J Pisani, Shinji Saitoh, Yoshihide Mitani, Alison L Marsden, Jesse M Engreitz, Jakob Körbelin, Marlene Rabinovitch
Förderung
- American Heart Association-American Stroke Association
- NIH HHS
- NHGRI NIH HHS
- NHLBI NIH HHS
- NCRR NIH HHS
Zitieren
APA
Shinohara, T., Moonen, J. R., Chun, Y. H., Lee-Yow, Y. C., Okamura, K., Szafron, J. M., Kaplan, J., Cao, A., Wang, L., Guntur, D., Taylor, S., Isobe, S., Dong, M., Yang, W., Guo, K., Franco, B. D., Pacharinsak, C., Pisani, L. J., Saitoh, S., …, & Rabinovitch, M. (2025). High Shear Stress Reduces ERG Causing Endothelial-Mesenchymal Transition and Pulmonary Arterial Hypertension. Arteriosclerosis, Thrombosis, and Vascular Biology, 45(2), 218-237. https://doi.org/10.1161/atvbaha.124.321092
Vancouver
Shinohara T, Moonen JR, Chun YH, Lee-Yow YC, Okamura K, Szafron JM, et al. High Shear Stress Reduces ERG Causing Endothelial-Mesenchymal Transition and Pulmonary Arterial Hypertension. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025;45(2):218-237. doi:10.1161/atvbaha.124.321092
BibTeX
@article{Shinohara2025,
author = {Shinohara, Tsutomu and Moonen, Jan-Renier and Chun, Yoon Hong and Lee-Yow, Yannick C and Okamura, Kenichi and Szafron, Jason M and Kaplan, Jordan and Cao, Aiqin and Wang, Lingli and Guntur, Divya and Taylor, Shalina and Isobe, Sarasa and Dong, Melody and Yang, Weiguang and Guo, Katherine and Franco, Benjamin D and Pacharinsak, Cholawat and Pisani, Laura J and Saitoh, Shinji and Mitani, Yoshihide and Marsden, Alison L and Engreitz, Jesse M and Körbelin, Jakob and Rabinovitch, Marlene},
title = {High Shear Stress Reduces ERG Causing Endothelial-Mesenchymal Transition and Pulmonary Arterial Hypertension},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2025},
volume = {45},
number = {2},
pages = {218--237},
doi = {10.1161/atvbaha.124.321092}
}
EUVIMED